InvestSMART

BCAL Diagnostics Limited (ASX: BDX) - Announcements

Current share price for BDX : $0.081 0.004 (4.71%)+

ASX company news and announcements for BCAL Diagnostics Limited (BDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BCAL Diagnostics Limited (BDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BCAL Diagnostics Limited (BDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BCAL Diagnostics Limited (BDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$30 AGM Date and Director Nominations 4 Oct 2024 8:37AM $0.140 $0.081 fallen by 42.14%
$30 Appendix 4G Corporate Governance Statement 27 Sep 2024 7:33PM $0.130 $0.081 fallen by 37.69%
$30 BCAL Secures Commercial Licence Agreement with SBC 23 Sep 2024 9:41AM $0.120 $0.081 fallen by 32.50%
$30 Corporate Presentation September 2024 19 Sep 2024 2:36PM $0.120 $0.081 fallen by 32.50%
$30 Cleansing Notice 17 Sep 2024 5:34PM $0.115 $0.081 fallen by 29.57%
$30 Application for quotation of securities - BDX 17 Sep 2024 5:26PM $0.115 $0.081 fallen by 29.57%
$30 Change of Director's Interest Notice 17 Sep 2024 5:13PM $0.115 $0.081 fallen by 29.57%
$30 Change of Director's Interest Notice 5 Sep 2024 5:38PM $0.115 $0.081 fallen by 29.57%
$30 Appendix 4E and Annual Report to Shareholders 30 Aug 2024 5:27PM $0.125 $0.081 fallen by 35.20%
$30 BCAL Commences US Operations 28 Aug 2024 10:10AM $0.130 $0.081 fallen by 37.69%
$30 Cleansing Notice 12 Aug 2024 8:15AM $0.120 $0.081 fallen by 32.50%
$30 Application for quotation of securities - BDX 12 Aug 2024 8:15AM $0.120 $0.081 fallen by 32.50%
$30 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2024 8:28AM $0.130 $0.081 fallen by 37.69%
$30 Directors Change of Interest Notice X 3 25 Jul 2024 1:12PM $0.115 $0.081 fallen by 29.57%
$30 Cleansing Notice 23 Jul 2024 5:58PM $0.130 $0.081 fallen by 37.69%
$30 Application for quotation of securities - BDX 23 Jul 2024 5:28PM $0.130 $0.081 fallen by 37.69%
$30 Results of Meeting 15 Jul 2024 1:41PM $0.150 $0.081 fallen by 46%
$30 BCAL to Present at Bioshares Biotech Summit - Presentation 11 Jul 2024 3:59PM $0.150 $0.081 fallen by 46%
$30 Change in substantial holding 21 Jun 2024 4:48PM $0.105 $0.081 fallen by 22.86%
$30 Change of Director's Interest Notice 17 Jun 2024 8:20AM $0.105 $0.081 fallen by 22.86%
$30 Letter to Shareholders re General Meeting 15 July 2024 13 Jun 2024 6:16PM $0.110 $0.081 fallen by 26.36%
$30 Notice of General Meeting/Proxy Form 13 Jun 2024 3:59PM $0.110 $0.081 fallen by 26.36%
$30 Cleansing Notice 11 Jun 2024 5:10PM $0.110 $0.081 fallen by 26.36%
$30 Application for quotation of securities - BDX 11 Jun 2024 5:00PM $0.110 $0.081 fallen by 26.36%
$30 Reinstatement to Quotation 3 Jun 2024 9:58AM $0.175 $0.081 fallen by 53.71%

101 - 125 of 274 results

Page 5 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.